Skip to main content
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: Follow-up 1 year aftercessation of treatment
Published Web Location
http://europepmc.org/articles/PMC3964491?pdf=renderNo data is associated with this publication.
Abstract
OBJECTIVE: We previously reported that 2 years of costimulation modulation with abatacept slowed decline of β-cell function in recent-onset type 1 diabetes (T1D). Subsequently, abatacept was discontinued and subjects were followed to determine whether ther
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.